Chancery Tosses Insider Financing Suit Against Ayala Brass
law360
4 weeks ago
20 views
The Delaware Chancery Court has dismissed a stockholder derivative suit against several venture capital investors and directors of biotechnology company Ayala Pharmaceuticals Inc., ruling that the plaintiff failed to show the board could not independently evaluate litigation over a disputed 2023 financing deal.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.